2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $527M | $537M | $579M | $543M | $566M |
Cost of Revenue | $338M | $351M | $385M | $340M | $0 |
Gross Profit | $189M | $186M | $193M | $204M | $566M |
Gross Profit % | 36% | 35% | 33% | 37% | 100% |
R&D Expenses | $0 | $0 | $0 | $0 | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | $41M | $29M | -$32M | $8.8M | $12M |
Dep. & Amort. | $8.1M | $9.3M | $13M | $14M | $13M |
Def. Tax | -$5M | -$2.7M | -$12M | -$1.6M | -$1.6M |
Stock Comp. | $2.5M | $4M | $4.3M | $3.8M | $4.3M |
Chg. in WC | -$14M | -$32M | -$35M | $51M | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $5.2M | $8.9M | $18M | $20M | $19M |
ST Investments | $0 | $0 | $0 | $0 | $0 |
Cash & ST Inv. | $5.2M | $8.9M | $18M | $20M | $19M |
Receivables | $142M | $151M | $161M | $153M | $147M |
Inventory | $90M | $121M | $125M | $98M | $97M |
Consolidated revenue for the fourth quarter decreased by 1% year-over-year, with positive growth in healthcare, apparel, and contact centers offset by a decline in the branded product segment. Full-year revenue guidance for 2025 is projected at $585M to $595M, suggesting up to 5% growth.
Fourth-quarter diluted EPS was $0.13, down from $0.22 in the prior year. Full-year EPS for 2025 is expected to range between $0.75 and $0.82, indicating up to 12% growth.
The company reduced its outstanding debt to $86M at year-end 2024 from $93M a year earlier and generated strong operating cash flow of $33M. A new $17.5M share repurchase program was authorized, reflecting confidence in future cash flow.
Gross margins varied across segments: branded products saw a decline due to sourcing mix and lower volume, healthcare apparel faced higher costs from manufacturing in Haiti, while contact centers achieved improved margins at 54.7%.
Strategic investments are being made in sales, branding, and technology across segments to drive growth and efficiency. The company anticipates a back-end weighted revenue pattern for 2025, with gradual improvement throughout the year.